Physician

Sean Tomas Kearin, MD

According to 2025 Medicare claims, Sean Kearin, MD (NPI: 1457511941) practices hematology/oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is HEALTH FIRST MEDICAL GROUP, LLC (NPI: 1750626495; TIN: 461243081) and primary practice location at 32940-2240. Kearin is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Kearin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 954 traditional Medicare patients, billed 208,915 HCPCS/CPT codes, and received $3,481,236 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,931 prescription claims across 296 beneficiaries totaling $5,195,788 in drug costs, led by Pomalyst (Pomalidomide). 2023 DME data shows 35 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $22,793 to $3,481,236. Similarly, Part D prescription costs have moved sharply higher in recent years, from $62,418 to $5,195,788. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,181 to $4,353.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	146	221	$22,793
2016	154	353	$25,740
2017	70	119	$6,221
2018	452	32,992	$453,752
2019	529	210,092	$2,959,198
2020	741	308,333	$5,244,066
2021	627	124,561	$1,547,717
2022	751	152,617	$2,286,795
2023	930	179,982	$2,960,721
2024	954	208,915	$3,481,236

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	32	$62,418
2016	53	295	$373,216
2017	57	173	$333,153
2018	115	406	$535,919
2019	199	1,008	$1,442,208
2020	321	1,988	$3,945,165
2021	227	881	$1,276,352
2022	235	1,218	$2,386,018
2023	258	1,544	$3,028,416
2024	296	1,931	$5,195,788

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	77	255	$10,023
2020	91	378	$18,808
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	35	$506
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	131	331	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	266	647	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	447	712	$64
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	130	287	$47
96372	Injection of drug or substance under skin or into muscle	125	300	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	39	1,092	$875,807
Ibrance	Palbociclib	37	1,050	$590,128
Imbruvica	Ibrutinib	35	980	$534,795
Revlimid	Lenalidomide	27	714	$432,671
Lenvima	Lenvatinib Mesylate	17	510	$406,491

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Sean Tomas Kearin, MD?

Tedicare shows public-source Medicare data for Sean Tomas Kearin, MD (NPI 1457511941), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sean Tomas Kearin, MD have ACO affiliation data?

Sean Tomas Kearin, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to Sean Tomas Kearin, MD?

Sean Tomas Kearin, MD is linked to HEALTH FIRST MEDICAL GROUP, LLC (billing NPI 1750626495) in the available physician profile data.

Does Sean Tomas Kearin, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.